Blog
RSS FeedPosted by Michael Wonder on 28 May 2020
COVID-19: researchers halt patient recruitment for hydroxychloroquine trial
28 May 2020 - Australian researchers have suspended patient recruitment in a major clinical trial of the controversial anti-malaria drug ...
Posted by Michael Wonder on 28 May 2020
Off-label drugs a risky business
28 May 2020 - Three years ago a 64cm blood clot caused by a drug used to treat acne, Diane ...
Posted by Michael Wonder on 28 May 2020
Australia avoids 'risky business' of coronavirus vaccine sweepstakes
27 May 2020 - Australia is avoiding huge financial risks by staying out of the global sweepstakes on coronavirus vaccines. ...
Posted by Michael Wonder on 26 May 2020
Australians stick with malaria drug hydroxychoroquine trial
26 May 2020 - Australian researchers are pressing ahead with administering the controversial antimalarial drug hydroxychloroquine in at least one ...
Posted by Michael Wonder on 25 May 2020
TGA approves Rozlytrek
25 May 2020 - Roche secures TGA approval for another cancer medicine. ...
Posted by Michael Wonder on 18 May 2020
Australia must work to avoid 'vaccine nationalism', former top bureaucrat warns
18 May 2020 - A former top bureaucrat has warned the international race to develop a vaccine against the novel ...
Posted by Michael Wonder on 18 May 2020
COVID-19 vaccine frontrunners emerge as rollout debate rages
18 May 2020 - Governments and drug makers are weighing how to roll out coronavirus vaccines, including reserving the first ...
Posted by Michael Wonder on 12 May 2020
ZolpiMist update
12 May 2020 - SUDA submitted a marketing authorisation application to the TGA for ZolpiMist in April 2019. ...
Posted by Michael Wonder on 08 May 2020
Influenza vaccines released for 2020 season
8 May 2020 - Six influenza vaccines are available in Australia in 2020. All of these vaccines are quadrivalent, which ...
Posted by Michael Wonder on 07 May 2020
CSL Behring Australia commences development of treatment for serious cases of COVID-19
6 May 2020 - Plasma-derived therapeutic with potential to treat serious complications of COVID-19. ...
Posted by Michael Wonder on 06 May 2020
Australia lacks vaccine making capacity, Defence report warns
6 May 2020 - Australia lacks the facilities and know-how to make its own pandemic vaccines, a report to government ...
Posted by Michael Wonder on 06 May 2020
COVID-19: potentially life saving immunoglobulin treatment for seriously ill Australians
6 May 2020 - The Australian Government welcomes the announcement by CSL Behring that Australia will be one of the first ...
Posted by Michael Wonder on 06 May 2020
Half yearly performance snapshot: July to December 2019
6 May 2020 - The TGA prepares an annual TGA Business Plan, which identifies the priority activities being undertaken over the ...
Posted by Michael Wonder on 06 May 2020
CSL ramps up development of COVID-19 plasma treatment
6 May 2020 - Australia’s biggest health company CSL has confirmed it will immediately begin development of plasma-derived therapy to ...
Posted by Michael Wonder on 05 May 2020
Bill Gates donates $10 million to Australian trial of immune-boosting vaccine
5 May 2020 - Bill Gates has donated $10 million to an Australian trial of a vaccine that researchers hope ...